# OnCo record boehringer-ingelheim (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/boehringer-ingelheim/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "boehringer-ingelheim" ;
  schema:name "Boehringer Ingelheim"@en ;
  schema:description "Private German pharma whose zongertinib became the first oral HER2 inhibitor for lung cancer."@en ;
  schema:url <https://onco.cc/companies/boehringer-ingelheim/>, <https://www.boehringer-ingelheim.com> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Boehringer_Ingelheim> ;
  owl:sameAs <http://www.wikidata.org/entity/Q699532> ;
  schema:citation <https://www.boehringer-ingelheim.com> ;
  schema:addressCountry "DE" ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:drugs <https://onco.cc/drugs/zongertinib/>, <https://onco.cc/drugs/tasonermin/> ;
  onco:companies <https://onco.cc/companies/nbe-therapeutics/> ;
  onco:trials <https://onco.cc/trials/nct07472517/>, <https://onco.cc/trials/nct07195695/>, <https://onco.cc/trials/nct06324357/>, <https://onco.cc/trials/nct06581432/>, <https://onco.cc/trials/nct07486817/>, <https://onco.cc/trials/nct06151574/>, <https://onco.cc/trials/nct07544654/>, <https://onco.cc/trials/nct05882058/>, <https://onco.cc/trials/nct06619509/> .